Article Text

PDF
RSV and bronchiolitis
  1. H L A Van Rostenberghe,
  2. S T Kew,
  3. M J M Hanifah
  1. Universiti Sains Malaysia, 16300 Kubang Kerian Kelantan Kota Bharu, Malaysia; hansvr@kb.usm.my

    Statistics from Altmetric.com

    In the study by Bala and colleagues,1 it seems that interpretations on cost effectiveness of palivizumab are made based on the number of admissions for bronchiolitis alone.

    We conducted an epidemiological study to determine the importance of respiratory syncytial virus (RSV) in the region on 412 …

    View Full Text

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.